Leading Genomic Services Company and Its Partners Raise More

Leading Genomic Services Company and Its Partners Raise More Than
$150,000 in Support of Pediatric Genetics Research 
Expression Analysis Concludes Its Fifth Annual "Leave Your
Fingerprint on the Cure(TM)" Fundraising Campaign, Donates This
Year's Funds to UCSF Benioff Children's Hospital 
SAN FRANCISCO, CA -- (Marketwire) -- 11/09/12 --  Expression Analysis
(EA), a Quintiles Company, has raised more than $27,000 for the UCSF
Benioff Children's Hospital at the 62nd Annual Meeting of the
American Society of Human Genetics (ASHG) in San Francisco. The
donation benefits the pediatric genetics division, which allows
researchers to diagnose childhood diseases more precisely, predict
their course, and create more effective treatments with fewer side
effects. 
EA's "Leave Your Fingerprint on the Cure" campaign asked ASHG
attendees to help complete a mural to earn corporate donations for
the hospital. Each person who painted a flower and left his or her
fingerprint on a large mural triggered a $75 donation to the UCSF
Benioff Children's Hospital. This is EA's fifth year at ASHG hosting
this campaign, which has generated more than $150,000 for pediatric
genetics research. The campaign is one of many programs that EA leads
to aid academic and industry researchers in uncovering genetic
markers linked to complex diseases.  
"We are honored that EA has chosen to support UCSF Benioff Children's
Hospital, notably our Division of Pediatric Genetics through this
unique fundraising initiative," said Anthony Wynshaw-Boris, MD,
Chief, Pediatric Genetics, UCSF Benioff Children's Hospital. "The
generous donation will help our researchers continue the important
work in better understanding genetic disease and developing new
therapies."  
"EA's Leave Your Fingerprint on the Cure campaign has grown
exponentially over the past five years, with donations up from $10
per fingerprint in 2008 to $75 today. Through the help of our
corporate sponsors, the campaign has raised more than $150,000 for
research in pediatric medical genetics for seven hospitals across the
United States," said Steve McPhail, President and CEO of EA. "I
sincerely thank this year's cosponsors Illumina, Raindance
Technologies, Life Technologies, Fluidigm, Qiagen, Golden Helix and
Ingenuity. This campaign has become an impor
tant part of who EA is --
a company dedicated to providing industry-leading tools and services
that accelerate the pace of genetic research leading to improved
diagnosis, treatment and management of complex disease." 
About EA
 EA, a Quintiles company, provides cutting-edge genomic
sequencing, gene expression, genotyping, and bioinformatics services
to the world's largest pharmaceutical companies, diagnostic test
developers, government agencies, and academic labs. All projects are
conducted under clinical-grade quality control, ensured through CLIA
certification, GLP compliance, and adherence to CLSI guidelines. EA's
bioinformatics staff are key contributors to the Food and Drug
Administration's MicroArray Quality Control (MAQC) and Sequencing
Quality Control (SEQC) studies, which aim to improve standards and
quality measures for reliable use of next-generation sequencing and
gene expression technologies in clinical practice and regulatory
decision-making. As part of its mission to improve human health, EA
has donated more than $2.2 million towards academic genomic research
grants, including more than $150,000 as part of the "Leave Your
Fingerprint on the Cure" Campaign for pediatric genetic research
hosted at the American Society for Human Genetics annual meeting. 
About Quintiles
 Quintiles is the world's leading provider of
biopharmaceutical services. With a network of more than 27,000
professionals working in more than 80 countries, we have helped
develop or commercialize all of the top 50 best selling drugs on the
market. With extensive therapeutic, scientific and analytics
expertise, we help biopharmaceutical and health sciences customers
navigate the increasingly complex landscape with more predictability
to enable better outcomes.  
FORWARD INQUIRES TO:
Karen Michailo
Office: 919-287-4277
Cell: 919-349-3687
kmichailo@expressionanalysis.com 
MEDIA INQUIRIES:
Alan Zachary, Ph.D.
Office: 312-506-5220
Cell: 708-707-6834
azachary@harrisdmckinney.com 
Ryan Ferrell
Office: 312-506-5202
Cell: 312-208-8600
rferrell@harrisdmckinney.com 
 
 
Press spacebar to pause and continue. Press esc to stop.